跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Myborte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Myborte
Approved
STANDARD
Myborte
Dr. Reddy's Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f514a562a7ae7b4
Company
Dr. Reddy's Laboratories Limited
Type
Standard
Approval Details
Approval Id
1f514a562a7ae7b4
Drug Approval Philippines Name
Myborte
Product Name
Myborte
Registration Number
DR-XY46740
Brand Name
Myborte
Generic Name
Bortezomib
Dosage Form
Lyophlized Powder for IV Infusion
Dosage Strength
3.5mg
Manufacturer
Dr. Reddy's Laboratories Limited
Importer
Dr. Reddy's Laboratories Philippines Inc.
Distributor
Dr. Reddy's Laboratories Philippines Inc.
Company Detail Path
/organization/dr-reddys-laboratories-limited
Issuance Date
27 October 2024
Expiry Date
13 November 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f514a562a7ae7b4
Type
Standard
Back to Philippines FDA Approvals